Q32 Bio (QTTB) Profit After Tax (2017 - 2026)

Q32 Bio's Profit After Tax history runs 10 years deep, the most recent figure standing at -$7.6 million for Q1 2026.

• On a quarterly basis, Profit After Tax rose 31.02% year-over-year to -$7.6 million in Q1 2026; TTM through Mar 2026 was $33.2 million, a 155.58% increase from a year earlier, with the FY2025 full-year figure at $29.8 million, up 162.47% from the prior year.
• Profit After Tax fell to -$7.6 million in Q1 2026 per QTTB's latest filing, from $57.7 million in the prior quarter.
• Across five years, Profit After Tax topped out at $92.1 million in Q1 2022 and bottomed at -$34.3 million in Q4 2022.
• The 5-year median for Profit After Tax is -$9.5 million (2025), against an average of -$1.8 million.
• Across the five-year window, Profit After Tax surged 8683.88% in 2022 and slumped 1172.01% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$34.3 million in 2022, then soared by 177.63% to $26.6 million in 2023, then sank by 153.3% to -$14.2 million in 2024, then soared by 506.8% to $57.7 million in 2025, then slumped by 113.18% to -$7.6 million in 2026.
• Per Business Quant, the three latest QTTB Profit After Tax figures stand at -$7.6 million (Q1 2026), $57.7 million (Q4 2025), and -$7.4 million (Q3 2025).